French biotechs afflicted by a plunge in financial support – FierceBiotech

“The sector has reached maturity in France in terms of products in phase 2 and 3,” noted André Choulika, the France Biotech president and CEO of Cellectis, according to Nature. “The total number of these products is now equal to a top ten …